Legend Biotech has managed to remove GenScript Biotech as its majority shareholder, just as the former parent’s Chinese background falls under a U.S. biosecurity microscope. After a financial maneuver ...

Analysts expect annual sales of Carvykti, Legend Biotech’s core cancer therapy, to peak at $7.3 billion With about $2 billion in cash reserves, Genscript isn’t under pressure to sell its 48% holding ...

Two months of “residential surveillance” have now been turned into an official arrest for Fangliang “Frank” Zhang, the founder of Chinese CDMO giant Genscript Biotech and its CAR-T subsidiary Legend ...

Genscript Biotech plunged in Hong Kong by the most in two months after its chairman was detained on suspicion of smuggling prohibited goods in and out of the country. Zhang Fangliang, a co-founder of ...

Hong Kong biotech GenScript has had a turbulent 48 hours, with its shares plummeting yesterday on allegations of data falsification in a CAR-T program, only to rebound after it strongly denied the ...